Robert E Bristow

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay
    Robert E Bristow
    University of California, Irvine Medical Center, Orange, CA, USA
    Gynecol Oncol 128:252-9. 2013
  2. ncbi The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Gynecol Oncol 118:262-7. 2010
  3. ncbi Racial disparities in ovarian cancer surgical care: a population-based analysis
    Robert E Bristow
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine School of Medicine, Orange, CA 92868, USA
    Gynecol Oncol 121:364-8. 2011
  4. ncbi Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center
    Robert E Bristow
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine School of Medicine, Orange, CA 92868, USA
    Gynecol Oncol 122:319-23. 2011
  5. ncbi Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 106:476-81. 2007
  6. ncbi Impact of surgeon and hospital volume on short-term outcomes and cost of oropharyngeal cancer surgical care
    Christine G Gourin
    Department of Otolaryngology Head and Neck Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Laryngoscope 121:746-52. 2011
  7. ncbi Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?
    Edward J Tanner
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Gynecol Oncol 117:336-40. 2010
  8. ncbi Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer
    Antonio Santillan
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 N Wolfe Street, Phipps 281, Baltimore, MD 21287 1281, USA
    Gynecol Oncol 104:686-90. 2007
  9. ncbi Impact of surgeon and hospital volume on short-term outcomes and cost of laryngeal cancer surgical care
    Christine G Gourin
    Department of Otolaryngology Head and Neck Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Laryngoscope 121:85-90. 2011
  10. ncbi Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, MD 21287, USA
    Gynecol Oncol 114:173-7. 2009

Detail Information

Publications88

  1. ncbi Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay
    Robert E Bristow
    University of California, Irvine Medical Center, Orange, CA, USA
    Gynecol Oncol 128:252-9. 2013
    ....
  2. ncbi The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Gynecol Oncol 118:262-7. 2010
    ..To examine the effect of hospital procedure volume and other prognostic variables on overall survival outcome and likelihood of receiving standard recommended care among patients with advanced-stage epithelial ovarian cancer...
  3. ncbi Racial disparities in ovarian cancer surgical care: a population-based analysis
    Robert E Bristow
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine School of Medicine, Orange, CA 92868, USA
    Gynecol Oncol 121:364-8. 2011
    ..To investigate differences according to racial classification in the frequency of ovarian cancer-related surgical procedures and in access to high-volume surgical providers among women undergoing initial surgery for ovarian cancer...
  4. ncbi Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center
    Robert E Bristow
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine School of Medicine, Orange, CA 92868, USA
    Gynecol Oncol 122:319-23. 2011
    ..To examine disparities in delivery of care and survival according to racial classification among White and African-American women with Stage IIIC epithelial ovarian cancer undergoing initial treatment in a tertiary referral center setting...
  5. ncbi Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 106:476-81. 2007
    ..To evaluate the cost-effectiveness of intraperitoneal cisplatin and paclitaxel chemotherapy as front-line treatment for patients with Stage III epithelial ovarian cancer following optimal primary cytoreductive surgery...
  6. ncbi Impact of surgeon and hospital volume on short-term outcomes and cost of oropharyngeal cancer surgical care
    Christine G Gourin
    Department of Otolaryngology Head and Neck Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Laryngoscope 121:746-52. 2011
    ..To evaluate the impact of surgeon and hospital case volume and other related variables on short-term outcomes after surgery for oropharyngeal cancer...
  7. ncbi Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?
    Edward J Tanner
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Gynecol Oncol 117:336-40. 2010
    ....
  8. ncbi Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer
    Antonio Santillan
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 N Wolfe Street, Phipps 281, Baltimore, MD 21287 1281, USA
    Gynecol Oncol 104:686-90. 2007
    ..To evaluate the feasibility and associated survival outcome of secondary cytoreductive surgery in patients with isolated lymph node recurrence of epithelial ovarian cancer...
  9. ncbi Impact of surgeon and hospital volume on short-term outcomes and cost of laryngeal cancer surgical care
    Christine G Gourin
    Department of Otolaryngology Head and Neck Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Laryngoscope 121:85-90. 2011
    ..To evaluate the impact of surgeon and hospital case volume and other related variables on short-term outcomes after surgery for laryngeal cancer...
  10. ncbi Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, MD 21287, USA
    Gynecol Oncol 114:173-7. 2009
    ..To describe the operative technique and associated clinical outcomes of patients undergoing rectosigmoid colectomy as a component of secondary cytoreductive surgery for recurrent ovarian cancer...
  11. ncbi Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice
    Antonio Santillan
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Gynecol Oncol 109:388-93. 2008
    ..S. healthcare system of implementing a clinical pathway for Pap test utilization in screening and surveillance of gynecologic cancers in a university-based gynecologic oncology practice...
  12. ncbi Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93
    Stefanie M Ueda
    Kelly Gynecologic Oncology Service, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Am J Pathol 175:2618-24. 2009
    ..FASN inhibitors such as C93 warrant further investigation as targeted therapeutic agents for metastatic and chemoresistant gestational trophoblastic neoplasia...
  13. ncbi Fertility preserving options in patients with gynecologic malignancies
    Ramez N Eskander
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California Irvine, Orange, CA, USA
    Am J Obstet Gynecol 205:103-10. 2011
    ..quot; The following review summarizes fertility sparing options for patients with cervical, ovarian and endometrial cancer, with an emphasis on appropriate patient selection, oncologic, and obstetric outcomes...
  14. ncbi Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 90:519-28. 2003
    ....
  15. ncbi Analysis of contemporary trends in access to high-volume ovarian cancer surgical care
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Ann Surg Oncol 16:3422-30. 2009
    ..However, contemporary patterns of primary surgical care for ovarian cancer according to hospital and surgeon case volume remain poorly defined...
  16. ncbi A clinical pathway for patients undergoing primary cytoreductive surgery with rectosigmoid colectomy for advanced ovarian and primary peritoneal cancers
    Melissa A Gerardi
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 108:282-6. 2008
    ....
  17. ncbi Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome
    Ritu Salani
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Cancer 109:685-91. 2007
    ....
  18. ncbi Uterine cancer in Maryland: impact of surgeon case volume and other prognostic factors on short-term mortality
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 103:1043-7. 2006
    ..To characterize the patterns of primary surgical care and short term outcomes for uterine cancer according to surgeon and hospital case volume...
  19. ncbi Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Cancer 109:1513-22. 2007
    ..The objective of this study was to evaluate the cost-effectiveness of centralized referral of patients with advanced-stage epithelial ovarian cancer who underwent primary cytoreductive surgery and adjuvant chemotherapy...
  20. ncbi Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Int J Gynecol Cancer 22:273-9. 2012
    ..The aim of this study was to determine if comprehensive surgical staging is a better predictor of outcome than incomplete staging for women with stage I noninvasive or minimally invasive (≤3 mm) uterine serous carcinoma (USC)...
  21. ncbi Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range
    Antonio Santillan
    Kelly Gynecology Oncology Service, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    J Clin Oncol 23:9338-43. 2005
    ..To evaluate the risk of epithelial ovarian cancer (EOC) recurrence in patients with rising serum cancer antigen 125 (CA-125) levels that remain below the upper limit of normal (< 35 U/mL)...
  22. ncbi Recurrent micropapillary serous ovarian carcinoma
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 1246, USA
    Cancer 95:791-800. 2002
    ....
  23. ncbi A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model
    Giovanni D Aletti
    Department of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Gynecol Oncol 107:99-106. 2007
    ..To test the feasibility and utility of a risk-adjusted, multicenter outcomes model for ovarian cancer surgery as a tool for quality improvement...
  24. ncbi Concentration of uterine cancer surgical care among the elderly: a population-based perspective
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 107:436-40. 2007
    ..To characterize the primary surgical care and short-term outcomes for uterine cancer in women age > or = 80 years compared to younger women...
  25. ncbi Surgical care of young women diagnosed with ovarian cancer: a population-based perspective
    Edward J Tanner
    Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, USA
    Gynecol Oncol 111:221-5. 2008
    ..To characterize primary surgical care for women with ovarian cancer aged </=50 years versus > 50 years...
  26. ncbi Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma
    Ritu Salani
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 N Wolfe St Phipps 281, Baltimore, Maryland 21224, USA
    Ann Surg Oncol 14:3552-7. 2007
    ....
  27. ncbi Prevention of adhesion formation after radical hysterectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 104:739-46. 2007
    ....
  28. ncbi Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitor
    Martina Bazzaro
    Department of Pathology, The Johns Hopkins University, Baltimore, Maryland 21231, USA
    Clin Cancer Res 14:7340-7. 2008
    ....
  29. ncbi Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 103:1070-6. 2006
    ..To determine the overall survival and relative effect of multiple prognostic variables in cohorts of patients with advanced-stage ovarian cancer treated with platinum-based neoadjuvant chemotherapy in lieu of primary cytoreductive surgery...
  30. ncbi Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 99:294-300. 2005
    ..To evaluate the utility of combined positron emission tomography/computed tomography (PET/CT) for detecting recurrent epithelial ovarian cancer limited to retroperitoneal adenopathy...
  31. ncbi Clinical significance of Her-2/neu overexpression in uterine serous carcinoma
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Gynecol Oncol 100:139-44. 2006
    ..To evaluate the clinico-pathologic characteristics and survival outcome associated with overexpression of Her-2/neu in patients with uterine serous carcinoma (USC)...
  32. ncbi Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement
    Kara Judson
    Department of Pathology, School of Public Health, The Johns Hopkins University, Baltimore, Maryland, USA
    Int J Gynecol Pathol 27:182-90. 2008
    ....
  33. ncbi Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Departments of Gynecology and Obstetrics and Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 115:334-8. 2009
    ..To evaluate the impact of surgeon and hospital case volume, and other related variables, on short-term outcomes after surgery for ovarian cancer...
  34. ncbi PET-CT in recurrent ovarian cancer: initial observations
    Harpreet K Pannu
    Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 600 N Wolfe St, Baltimore, MD 21287, USA
    Radiographics 24:209-23. 2004
    ..Combined functional-anatomic imaging can also increase diagnostic confidence at CT. Further study is needed to determine the possible benefits of lesion conspicuity at PET and anatomic localization at CT on fused PET-CT scans...
  35. ncbi Impact of surgeon specialty on ovarian-conserving surgery in young females with an adnexal mass
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    J Adolesc Health 39:411-6. 2006
    ....
  36. ncbi Salvage cytoreductive surgery for recurrent endometrial cancer
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Gynecol Oncol 103:281-7. 2006
    ..To determine the survival impact of salvage cytoreductive surgery, and other prognostic variables, among patients with recurrent endometrial cancer...
  37. ncbi Ovarian cancer surgery in Maryland: volume-based access to care
    Robert E Bristow
    Department of Biostatistics, Johns Hopkins Oncology Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 93:353-60. 2004
    ..To characterize the patterns of primary surgical care for ovarian cancer in a statewide population according to annual surgeon and hospital case volume...
  38. ncbi Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 103:709-13. 2006
    ..To examine the cost-effectiveness of routine vaginal cytology in detecting asymptomatic isolated vaginal recurrence during post-treatment endometrial cancer surveillance...
  39. ncbi The role of cytoreductive surgery for colon cancer metastatic to the ovary
    Colleen C McCormick
    Department of Gynecology and Obstetrics, Kelly Gynecologic Oncology Service, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Gynecol Oncol 105:791-5. 2007
    ..We sought to further elucidate the survival impact of cytoreductive surgery among patients with colon cancer metastatic to the ovary...
  40. ncbi Surgical care of elderly women with ovarian cancer: a population-based perspective
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 99:352-7. 2005
    ..To characterize the primary surgical care and short-term outcomes for ovarian cancer in women aged 80 years and older compared to women younger than 80 years...
  41. ncbi Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, Maryland 21287, USA
    Anticancer Res 29:2875-84. 2009
    ..To identify immunosuppressive elements present in ovarian cancer associated ascites...
  42. ncbi Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer
    Hannah H Alphs
    The Johns Hopkins School of Medicine, The Johns Hopkins University, Baltimore, MD 21287, USA
    Gynecol Oncol 103:1048-53. 2006
    ..Perioperative variables such as these can be used to identify the elderly patients that are most likely to be suboptimally cytoreduced and thus have a dismal survival outcome...
  43. ncbi Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: a case-control study
    Ritu Salani
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Gynecol Oncol 107:495-9. 2007
    ..To evaluate clinicopathological factors and survival outcome of patients with advanced epithelial ovarian carcinoma undergoing multiple bowel resections to achieve optimal (< or = 1 cm) cytoreduction...
  44. ncbi p53 autoantibodies, cytokine levels and ovarian carcinogenesis
    Miyun Tsai-Turton
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Gynecol Oncol 114:12-7. 2009
    ..To address the hypothesis that type II ovarian carcinoma, mutation of p53 and plasma levels of particular cytokines are associated with the generation of p53-specific serum autoantibody (AAb) responses in patients...
  45. ncbi Surgical management of epithelial ovarian cancer
    Ritu Salani
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Medical Center, Columbus, Ohio, USA
    Clin Obstet Gynecol 55:75-95. 2012
    ..Understanding the multiple roles of surgery throughout the disease course is the focus of this review...
  46. ncbi Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status
    Ritu Salani
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ohio State Medical Center, Columbus, OH 43210, USA
    Am J Obstet Gynecol 200:182.e1-5. 2009
    ..We sought to determine the value of conization margin status in predicting residual and recurrent adenocarcinoma in situ (ACIS) of the cervix...
  47. ncbi Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 NorthWolfe Street, Phipps 281, Baltimore, Maryland 21287, USA
    Gynecol Oncol 109:364-9. 2008
    ..To describe the operative techniques and associated clinical outcomes of patients undergoing transverse colectomy as a component of cytoreductive surgery for advanced or recurrent ovarian cancer...
  48. ncbi Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancers
    Lauren S Krill
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 120:220-3. 2011
    ..To evaluate the risk of postoperative complications related to HA-CMC use in patients undergoing optimal cytoreductive surgery for primary and recurrent ovarian, fallopian tube, and peritoneal cancers...
  49. ncbi Volume-based trends in surgical care of patients with oropharyngeal cancer
    Christine G Gourin
    Department of Otolaryngology Head and Neck Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Laryngoscope 121:738-45. 2011
    ..Positive volume-outcome relationships exist for diseases treated with technically complex surgery. Contemporary patterns of oropharyngeal cancer surgery by hospital and surgeon volume are poorly defined...
  50. ncbi Comparison of candidate serologic markers for type I and type II ovarian cancer
    Dan Lu
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA
    Gynecol Oncol 122:560-6. 2011
    ..To examine the value of individual and combinations of ovarian cancer associated blood biomarkers for the discrimination between plasma of patients with type I or II ovarian cancer and disease-free volunteers...
  51. ncbi Imaging uterine cervical cancer with FDG-PET/CT: direct comparison with PET
    Mitsuaki Tatsumi
    Division of Nuclear Medicine, Department of Radiology, Johns Hopkins Medical Institutions, 601 North Caroline Street, Baltimore, MD 21287 0817, USA
    Mol Imaging Biol 11:229-35. 2009
    ....
  52. ncbi Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, Maryland 21287, USA
    Gynecol Oncol 106:82-8. 2007
    ..To identify effective treatment options for patients with recurrent uterine leiomyosarcoma (LMS)...
  53. ncbi Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome
    Amer K Karam
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA
    Gynecol Oncol 104:377-80. 2007
    ..We sought to evaluate the impact of TCS on survival and to determine predictors of optimal tertiary resection...
  54. ncbi Expression of extracellular matrix proteins in ovarian serous tumors
    Ritu Salani
    Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA
    Int J Gynecol Pathol 26:141-6. 2007
    ..007). In summary, ovarian carcinomas exhibit up-regulated expression of several extracellular matrix proteins, and syndecan 1 represents a novel tumor-associated marker in ovarian serous carcinomas...
  55. ncbi A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: a Gynecologic Oncology Group study
    Deborah K Armstrong
    Johns Hopkins Kimmel Cancer Center, Bunting Blaustein Cancer Research Building, Baltimore, MD 21231 1000, USA
    Gynecol Oncol 105:667-71. 2007
    ....
  56. ncbi Surgical technique of diaphragm full-thickness resection and trans-diaphragmatic decompression of pneumothorax during cytoreductive surgery for ovarian cancer
    Shazia Bashir
    The Kelly Gynecology and Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 119:255-8. 2010
    ..To describe the technique and short-term post-operative outcomes associated with diaphragm full-thickness resection (FTR) and intraoperative trans-diaphragmatic decompression of the resultant pneumothorax (TDDP)...
  57. ncbi Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer
    Allison E Axtell
    University of California Los Angeles UCLA Medical Center, Los Angeles, CA, USA
    J Clin Oncol 25:384-9. 2007
    ..Reciprocally cross validate the predictors identified with those from two previously published cohorts from institutions B and C...
  58. ncbi Secondary cytoreduction for patients with recurrent ovarian cancer
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Curr Oncol Rep 7:451-8. 2005
    ..A clear understanding of the prognostic factors and expectations from the procedure are necessary in order to identify candidates adequately...
  59. ncbi Clinical utility of atypical glandular cells (AGC) classification: cytohistologic comparison and relationship to HPV results
    Teresa P Diaz Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 104:366-71. 2007
    ..To determine the utility of the category of atypical glandular cells (AGC) in the management of patients with putative cervical neoplasia and to correlate HPV-DNA test results when available...
  60. ncbi Computed tomographic peritoneography prior to intraperitoneal chemotherapy in advanced Müllerian cancer: a pilot study
    Joyce N Barlin
    Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Clin Imaging 34:191-5. 2010
    ..The objective of this study was to utilize computed tomographic peritoneography (CTP) to assess distribution prior to intraperitoneal chemotherapy for advanced müllerian cancer...
  61. ncbi Cytoreductive surgery for advanced or recurrent endometrial cancer: a meta-analysis
    Joyce N Barlin
    Department of Gynecology and Obstetrics, The Johns Hopkins Hospital, 600 North Wolfe St, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 118:14-8. 2010
    ..To determine the relative effect and quantify the impact of multiple prognostic variables on median overall survival time among cohorts of patients with advanced or recurrent endometrial cancer undergoing cytoreductive surgery...
  62. ncbi Predictive value of endocervical curettage at cervical conization and provider practices in management of high-grade cervical dysplasia
    Joyce N Barlin
    Department of Gynecology and Obstetrics, Johns Hopkins Hospital, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    J Reprod Med 55:129-33. 2010
    ..To determine the utility of endocervical curettage (ECC) at cervical conization for predicting residual or recurrent dysplasia and to evaluate differences in management between general gynecologists and gynecologic oncologists...
  63. ncbi Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer
    Robert E Bristow
    Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    J Am Coll Surg 197:565-74. 2003
    ..The associated morbidity is acceptable, and protective intestinal diversion appears unnecessary...
  64. ncbi Combined FDG-positron emission tomography and computed tomography for the detection of ovarian cancer recurrence in an inguinal hernia sac
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 98:510-2. 2005
    ..Combined positron emission tomography (PET) and computed tomography (CT) may have a potential role in the early detection and anatomical localization of recurrent ovarian cancer...
  65. ncbi Abdominal carcinomatosis in women with a history of breast cancer
    Ruchi Garg
    Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 N. Wolfe Street, Baltimore, MD 21287-1281, USA
    Gynecol Oncol 99:65-70. 2005
    ..Optimal cytoreductive surgery was associated with a significant survival advantage for patients with primary ovarian/peritoneal cancer...
  66. ncbi Predictors of extended intensive care unit resource utilization following surgery for ovarian cancer
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 107:464-8. 2007
    ....
  67. ncbi Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis
    Robert E Bristow
    Department of Gynecology, The Kelly Gynecologic Oncology Service, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 112:265-74. 2009
    ..To determine the relative effect of multiple prognostic variables on overall post-recurrence survival time among cohorts of patients with recurrent ovarian cancer undergoing cytoreductive surgery...
  68. ncbi Evaluation and management of adnexal masses during pregnancy
    Robert L Giuntoli
    Hopkins Medical Institutions, Phipps 281, Baltimore, Maryland 21287, USA
    Clin Obstet Gynecol 49:492-505. 2006
    ..In the approximately 5% of cases in which an adnexal masses proves to be a malignancy, appropriate staging may be safely performed. In selected cases, chemotherapy should at least be entertained...
  69. ncbi Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer
    Ritu Salani
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Gynecol Oncol 108:271-5. 2008
    ....
  70. ncbi Micropapillary serous ovarian carcinoma: surgical management and clinical outcome
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 86:163-70. 2002
    ....
  71. ncbi Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 104:480-90. 2007
    ..To summarize the existing data on interval cytoreductive surgery and neoadjuvant chemotherapy as alternative treatment strategies for patients with advanced-stage ovarian cancer...
  72. ncbi A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival
    Kentaro Nakayama
    Department of Pathology, Johns Hopkins Medical Institutions, 1550 Orleans Street, Baltimore, MD 21231, USA
    Proc Natl Acad Sci U S A 103:18739-44. 2006
    ....
  73. ncbi Predicting the outcome of cytoreductive surgery for advanced ovarian cancer: a review
    Okechukwu A Ibeanu
    Division of Gynecologic Oncology, School of Medicine, Johns Hopkins University, Baltimore, MD 21287, USA
    Int J Gynecol Cancer 20:S1-11. 2010
    ..Clinicopathological and radiological models for predicting optimal resectability have not been universally applicable...
  74. ncbi Role of obesity in the surgical management of advanced-stage ovarian cancer
    Adam J Wolfberg
    Department of Obstetrics and Gynecology, Brigham and Women s Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Reprod Med 49:473-6. 2004
    ....
  75. ncbi Ovarian cancer in elderly women
    Nicholas C Lambrou
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Miami, School of Medicine, Miami, Florida, USA
    Oncology (Williston Park) 17:1075-81; discussion 1081, 1085-6, 1091. 2003
    ..In addition, enhanced cooperation between geriatricians and oncologists may assist the pretreatment assessment of elderly patients and improve treatment guidelines in this population...
  76. ncbi Gynecologic abnormalities in surgically treated women with stage II or III rectal cancer
    Sven O Becker
    The Kelly Gynecologic Oncology Service, Departments of Gynecology and Obstetrics, The Johns Hopkins Hospital and Medical Institutions, Baltimore, MD 21287, USA
    J Am Coll Surg 194:315-23. 2002
    ..The utilization of prophylactic oophorectomy in postmenopausal women undergoing surgery for rectal cancer is currently not optimal; preoperative discussion should address this option...
  77. ncbi Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis
    Robert E Bristow
    Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD 21287 1248, USA
    J Clin Oncol 20:1248-59. 2002
    ..To evaluate the relative effect of percent maximal cytoreductive surgery and other prognostic variables on survival among cohorts of patients with advanced-stage ovarian carcinoma treated with platinum-based chemotherapy...
  78. ncbi Prevention of adhesion formation after radical oophorectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 99:301-8. 2005
    ....
  79. ncbi Surgery for ovarian cancer: how to improve survival
    Robert E Bristow
    Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Lancet 367:1558-60. 2006
  80. ncbi Positron emission tomography for detecting clinically occult surgically resectable metastatic ovarian cancer
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institution, Baltimore, Maryland 21287, USA
    Gynecol Oncol 85:196-200. 2002
    ....
  81. ncbi Multidetector CT of peritoneal carcinomatosis from ovarian cancer
    Harpreet K Pannu
    Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21287, USA
    Radiographics 23:687-701. 2003
    ..Interactive multiplanar review of the abdomen and pelvis has the potential to improve detection of peritoneal metastases at CT...
  82. ncbi Primary insular carcinoid of the ovary
    Teresa P Diaz-Montes
    Department of Gynecology and Obstetrics, The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 101:175-8. 2006
    ..Thus, there appears to be a good correlation between the size of the tumor and the presence of the carcinoid syndrome...
  83. ncbi Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors
    Marcela G del Carmen
    Department of Gynecology and Obstetrics Department of Oncology, The Johns Hopkins Hospital and Medical Institutions, Baltimore, Maryland, USA
    Cancer 98:1658-63. 2003
    ..Using immunohistochemical methods, we compared the differential expression patterns of various cytokines and growth factors in atypical endometriosis (AE) and EAOC...
  84. ncbi Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer
    C William Helm
    Division of Gynecologic Oncology, James Graham Brown Cancer Center, University of Louisville, Kentucky 40207, USA
    J Surg Oncol 98:283-90. 2008
    ....
  85. ncbi Cancer of the uterine corpus among Hispanic women living in the United States: patterns of staging, diagnosis, and primary treatment
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 96:753-9. 2005
    ..To evaluate the demographic characteristics, clinico-pathological features, and patterns of care of uterine cancer among Hispanic women living in the United States...
  86. ncbi Stage IV micropapillary serous ovarian carcinoma: a report of three cases
    Yong-Wook Kim
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Int J Gynecol Pathol 24:235-8. 2005
    ..These cases demonstrate the potential of MPSCs for aggressive clinical behavior and distant metastases...
  87. ncbi Paraneoplastic cerebellar degeneration in a woman with ovarian cancer
    Antonio Santillan
    Kelly Gynecologic Oncology Service, Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Nat Clin Pract Oncol 3:108-12; quiz 1 p following 112. 2006
    ....
  88. ncbi Cytoreductive surgery for advanced and recurrent endometrial cancer: a review of the literature
    Joyce N Barlin
    Department of Gynecology and Obstetrics, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Womens Health (Lond Engl) 5:403-11. 2009
    ....